Discover how cutting-edge tools and analytics are advancing cell therapy, improving precision, safety and scalability in ...

In this webinar, we demonstrate a use case for characterizing the health of starting donor material in cell therapy manufacturing using the Invitrogen™ Attune™ CytPix™ Flow Cytometer to monitor T-cell ...

Scientists from the Keck School of Medicine at University of Southern California have developed a spectral flow cytometry-based panel for profiling CAR T cells that could be used to optimize their ...

Cytolight Red A549 target cells were seeded at 5K cells/well into a 96-well plate in 4Cell ® Nutri-T GMP medium topped up with FBS. Cells were permitted to adhere for 3 hours in a 37 °C, 5 % CO ...

Study: Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers.Image Credit: Maryna Olyak/Shutterstock.com. In a recent study published in Nature, researchers tested whether ...

Cytek Biosciences launches the Aurora™ Evo, an advanced flow cytometer enhancing throughput and automation for cell analysis. Quiver AI Summary Cytek Biosciences, Inc. has announced the launch ...

Previously, Pereira et al described successful analysis of the miRNA content of red blood cell derived EVs (RBCEVs) using MBs and nano-flow cytometry. Therefore, in order to validate the plausibility ...

In a recent article, researchers explored how calcium carbonate nanoparticles enhance T cell activation through calcium signaling, offering new potential for improving cancer immunotherapy outcomes.

Candid joins a number of high-profile companies that are making waves in the space. In January 2024, MSD acquired Harpoon in a $680m deal, which included Harpoon’s T cell engagers. One of the ...

JNJ-4496, formerly known as C-CAR039, is a dual-targeting CAR T designed to bind to both CD19 and CD20 antigens — two cell surface proteins commonly expressed on malignant B-cells.